Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Cash from Investing Activities (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Cash from Investing Activities for 14 consecutive years, with -$3.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 46.19% year-over-year to -$3.4 million, compared with a TTM value of -$12.7 million through Sep 2025, down 93.68%, and an annual FY2024 reading of -$6.6 million, up 35.23% over the prior year.
  • Cash from Investing Activities was -$3.4 million for Q3 2025 at Sanara MedTech, up from -$3.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$12945.0 in Q2 2023 and bottomed at -$10.1 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$2.0 million, with a median of -$604391.0 recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 99.38% in 2023, then tumbled 7769.97% in 2025.
  • Year by year, Cash from Investing Activities stood at -$1.5 million in 2021, then skyrocketed by 74.73% to -$376954.0 in 2022, then soared by 85.6% to -$54276.0 in 2023, then crashed by 139.51% to -$129994.0 in 2024, then tumbled by 2531.5% to -$3.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SMTI at -$3.4 million in Q3 2025, -$3.9 million in Q2 2025, and -$5.2 million in Q1 2025.